siRNA-based Therapeutics

CONDITION ADDRESSED: Pre-eclampsia

Prevention
Prevention
Prevention
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT

CONTACT INFORMATION

Organization

University of Massachusetts Medical School

Individual Contact

 

Melissa J. Moore of the University of Massachusetts Medical School and S. Ananth Karumanchi of Harvard Medical School in the U.S. propose to develop siRNA-based therapies to silence genes in the placenta which produce excess proteins that cause preeclampsia. Temporarily silencing these genes can prolong pregnancy and protect the life of both infant and mother.

                                               

Information taken from Gates Foundation Grand Challenges Exploration Grants, awarded grants summaries.

Stage of Development

Early R&D

Funding Source

Bill & Melinda Gates Foundation